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Effects of transcutaneous electrical nerve
stimulation via peroneal nerve or soleus muscle
on venous ﬂow
A randomized cross-over study in healthy subjects
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Abstract
Background: Transcutaneous electrical nerve stimulation (TENS) is used to prevent venous stasis and thromboembolism.
However, best electrostimulation parameters have yet to be established. The aim of the study was to compare the hemodynamic
effects and the participants’ relative discomfort of 3 TENS sequences at the maximum tolerated intensity stimulus.
Methods: Twenty-four healthy university students (50% male) participated in a cross-over, randomized study. Each participant
received 2 TENS sequences on peroneal nerve at 1 and 5Hz, and the third one on soleus muscle at 5Hz. Popliteal ﬂow volume (FV)
and peak velocity (PV) were measured using Doppler ultrasound and the relative change from basal values was recorded. Discomfort
questionnaires -visual analogue scale (VAS) and verbal rating scale (VRS)- were also administered to compare sensations among the
three applications.
Results: All interventions produced signiﬁcant hemodynamic responses compared to baseline. Both 5Hz applications obtained
higher FV increments than 1Hz TENS (P< .001). The muscle application resulted in the lowest PV increment (P< .001). TENS at 5Hz
on nerve location was the worst tolerated, with higher values in VRS (P= .056) and VAS (P= .11), although not signiﬁcant.
Conclusion: TENS at 5Hz on soleus site may be the most appropriate protocol for enhancing venous return.
Abbreviations: ANOVA = analysis of variance, BMI = body mass index, DVT = deep vein thrombosis, ES = electrical stimulation,
FV = ﬂow volume, IPC = intermittent pneumatic compression, Musc = muscle, NMES = neuromuscular electrical stimulation, PE =
pulmonary embolism, PV = peak velocity, Q1 = ﬁrst quartile, Q3 = third quartile, SD = standard deviation, TENS = transcutaneous
electrical nerve stimulation, VAS = visual analogue scale, VRS = verbal rating scale, VTE = venous thromboembolism.
Keywords: hemodynamics, muscle, peroneal nerve, skeletal, transcutaneous electric nerve stimulation
1. Introduction
Many individuals are at risk for developing venous thromboem-
bolism (VTE), deﬁned as deep vein thrombosis (DVT), pulmonary
embolism (PE), or both. Three factors have been addressed
(Virchow triad) as causing VTE owing to immobilization, surgery,
or trauma injury: venous stasis, endothelial damage or increased
coagulation. There are 2 main types for preventing VTE: chemical
and physical. Despite chemical prophylaxis being the preferred
method, it has a high risk of bleeding andmust be avoided in some
patients. There is also increasing evidence supporting the use of
mechanical devices as intermittent pneumatic compression (IPC)
and compression stockings in surgical patients at high risk of
developingVTE.[1,2] Theseoptions can still have certain limitations
such as patient discomfort, tissue injury, improper ﬁtting,[2,3] or
arterial insufﬁciency in patients with peripheral arterial disease,[4]
so alternative physical strategies like electrical stimulation (ES) are
being investigated. ES has been shown to have an additive effect to
compression stockings[5] and to be at least as effective as IPC in
terms of the venous hemodynamic response,[6,7] and besides, to
show some other advantages such as arterial andmicrocirculatory
ﬂux enhancement.[8,9] In addition, ES can also play a speciﬁc role
by stimulating or replacing the neural supply to the veins, which
has been proposed recently as the fourth factor in thrombus
pathogenesis.[10] ESmay be evenmore necessarywhen early active
motion is difﬁcult or unavailable as in traumatology patients
because of an immobilized extremity or muscle inhibition after
surgery, and in critically ill patients.
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Electrical stimulation devices, like transcutaneous electrical
nerve stimulation (TENS) and neuromuscular electrical stimula-
tion (NMES), have been used to enhance venous hemodynamics
via motor nerves or via skeletal muscles. NMES and TENS are
different ES modalities, but there is confusion regarding the
description of the ES forms among researchers and clinicians.[11]
As both ES modalities can be delivered by surface electrodes for
stimulating muscles and nerves, the differences are related to their
original purpose. TENS has been primarily developed for pain
relief, whereas NMES has been primarily developed for the
improvement of muscle strength eliciting smooth tetanic muscle
contraction and relaxation, similar to an exercise therapy
session.[12] Therefore, an on-off time in seconds (duty-cycle) is
necessary in NMES for minimizing muscular fatigue and
discomfort,[13] a parameter not considered in TENS applica-
tions.[12]
Despite ES having been experimentally proved to be effective in
improving venous ﬂow and velocity,[14] the stimulation param-
eters vary greatly and it is necessary to clarify which parameters
are optimal for venous return.[15] Frequencies from 1 to 10Hz
have been tested at nerve locations.[8,16] To the best of the
authors’ knowledge, only one study has compared nerve to
muscle stimulation, but used different ES frequencies and
intensities for each placement.[16]
The primary objective of this study was to compare the
effect of frequency and electrode placement among 3 ES
applications at the maximum tolerated intensity on hemody-
namic popliteal venous ﬂow and peak velocity (PV) using
Doppler ultrasound in healthy volunteers. A further objective
was to compare the participants’ relative discomfort among the
3 applications using a visual analogue scale and verbal rating
scoring index.
2. Materials and methods
2.1. Design and sample
A large variation in hemodynamic response to ES has been
found in healthy population.[17] Therefore, a within-subjects
cross-over design was used to determine differences in hemody-
namic effects and discomfort. A random assignment of the ES
was used to avoid possible systematic effects of order (6 possible
sequences). The order of testing was introduced in opaque
envelopes to be randomly selected by each participant, who
was not aware of it. Study protocol was reviewed and approved
by the regional Clinical Research Ethics Committee of
Galicia (Spain) in accordance with the Helsinki Declaration.
Informed consent was obtained from each subject before
enrollment. This study is registered in the Research Registry
(researchregistry3380).
The optimal sample size was determined from a pilot sample of
12 subjects (6 men). The venous ﬂow volume (FV), in milliliter
per minute, was measured 3 times and the mean was considered,
both basal and after the ES protocol. The FV increment was
computed relatively with respect to basal levels, and given as
percentage. A 1-way analysis of variance (ANOVA) with
repeated-measures was used to compare the difference among
the 3 ES results. From the estimated correlation among repeated-
measures of 0.7 and a standard deviation within each group of
90%, we obtained that, with a sample size of 24 subjects, the test
would have a power of 0.8 to detect signiﬁcant differences in the
relative FV increments if they were 40%, 175%, and 150%, with
a type I error of 0.05.
2.2. Participants
Students from the Faculty of Physical Therapy (Universidade da
Coruña, Spain) were initially invited to participate in a screening
session. A university notice board was used to recruit the
volunteers. The speciﬁc inclusion criteria were: healthy subjects
aged between 18 and 39 years. Exclusion criteria included factors
that might affect venous return or current ﬂow: body mass index
(BMI)<18 or>30kg/m2, smokers, oral contraceptive use, recent
surgery/trauma to lower limbs, any diagnosed disease that could
affect hemodynamics, clinically signiﬁcant varicose veins, or
ulceration of the lower limbs. Among 27 volunteers assessed for
eligibility, 2 women and 1 man were excluded for meeting some
exclusion criteria. The pilot sample was included within the ﬁnal
sample of 24 subjects (12 men) selected for evaluation. All of
them completed the experimental session.
2.3. Experimental procedure
All examinations were performed in the same room, in which the
temperature was controlled (22°C–24°C). Environmental data
were recorded with a weather station (Oregon Scientiﬁc, Madrid,
Spain). Data collection occurred in March and April 2017.
The subjects lay in the prone position 15 to 20 minutes before
the experiment with their feet off the table and a soft cushion
beneath the ankle. Stimulation electrodes sites were previously
clipped of hairs. Three ES protocols were applied using a 2-
channel portable stimulator (TENSMED S82, ENRAF-NON-
IUS, Rotterdam, The Netherlands) and matching self-adhesive
electrodes. All the ES protocols selected were delivered without a
duty cycle (on-off time). Therefore, all of them were considered
TENS. Electrode placements (Fig. 1) were the left common
peroneal nerve,[16,18] and the motor points of the soleus
muscle,[19] where skin area was most responsive to ES.[20] A
charge-balanced biphasic square wave with phase duration of
0.35 milliseconds was applied at 1 and 5Hz over the nerve and at
5Hz over the muscle to obtain a twitch contraction. The
frequency of 5Hz[8] was chosen instead of 10Hz,[16] as 10Hzwas
felt uncomfortable and fatiguing because of the almost tetanic
muscle response it originated without a resting time. Stimulation
amplitude was increased gradually, 0.5mA per second to ﬁnd the
pain threshold for each application in the random order assigned.
The stimulation intensity was set 10% below the pain threshold,
and the values (median, ﬁrst–third quartiles) were 30.5 (22.1–43)
mA, 20.0 (14.5–24.3) mA, and 37.0 (25.5–51.5) mA when
applying 1Hz and 5Hz on nerve location, and 5Hz atmuscle site,
respectively.
2.4. Outcome measurements
2.4.1. Primary outcome. A baseline duplex venous ultrasound
scanwas performed at least 5minutes after the last pain threshold
determination. The popliteal vein of the nondominant leg was
examined with a 6 to 13MHz linear transducer (LOGIQ e BT12
General Electric Medical Systems). It was placed at the back of
the knee by a ﬁxed-arm, once the optimal location was reached.
Vein diameter was measured using B-mode. The venous FV
(millimeters per minute) was calculated by the Doppler unit’s
software. The venous PV (centimeters per second) was recorded
from the Doppler waveform. The electrical stimulation sequences
were applied for 1minute before recording echographic measures
during stimulation. They were followed by a 5-minute recovery
phase and a new baseline ultrasound was examined. Measure-
ments were taken over a period of 16seconds, to obtain several
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endogenous or ES-superimposed blood movement cycles. Three
measurements were made for each condition and the mean of
them was used for analysis. The same well-trained examiner with
>6 years of experience performed all measurements and asked
the subjects to remain stationary and maintain a stable breathing
pattern during data collection.
2.4.2. Secondary outcome. Participants compared discomfort
after the 3 TENS applications using a 100-mm visual analogue
score (VAS). This scale was modiﬁed from traditional pain VAS
with 0mm denoting no sensation, and 100mm indicating pain
onset. Subjects’ relative comfort perceptionwas also assessed by a
verbal rating score (VRS): 1, no sensation; 2, minimal discomfort;
3, mild discomfort; 4, moderate discomfort; and 5, severe
discomfort.
2.5. Statistical analysis
Data are presented as mean± standard deviation (SD); if the
distribution is asymmetrical, median and ﬁrst and third quartiles
(Q1 and Q3) are also given. The Kolmogorov-Smirnov-Lilliefors
test was used to test for normal distribution of the data.
Univariate effects of the ES with respect to baseline values were
studied with a paired t test, as all the differences were normally
distributed. To compare the effects in hemodynamics and
discomfort the 3 TENS applications, a 1-way ANOVA with
repeated-measures, or Friedman test was carried out. To identify
differences in the ES results, post hoc pairwise comparisons were
considered with Bonferroni correction. To ensure comparability,
standardized effect sizes were calculated by the partial eta-
squared h2p (partial variance explained in ANOVA). A P value
<.05 was assumed to denote statistical signiﬁcance. Statistical
analyses were carried out using IBM SPSS for Windows, version
21.0 (IBM Corporation).
3. Results
Table 1 presents the physical baseline characteristics of the
participants. Typical Doppler waveforms of baseline and the 3
TENS protocols (1 and 5Hz via nerve and 5Hz muscle) are
shown in Figure 2. The effect of the different TENS programs on
both FV and PV was statistically signiﬁcant (Table 2). The
increment of hemodynamics responses has been computed
relatively from baseline and given as a percentage (Table 3).
The relative increments of the hemodynamic responses (in %)
varied signiﬁcantly with the ES interventions for FV (P< .001)
and PV (P< .001). FVwas higher with TENS applications of 5Hz
than of 1Hz (P< .001). TENS protocols at 5Hz on peroneal
nerve and on soleus muscle were not signiﬁcantly different (P=
1.00). Regarding PV, TENS 5Hz on soleus muscle produced the
lowest changes. These changes were signiﬁcantly lower than for
TENS 1Hz (P< .001) and for 5Hz on peroneal nerve (P= .002).
Furthermore, no signiﬁcant difference on PV was found between
both applications on peroneal nerve (P= .22).
Comparative values of VAS and VRS for discomfort after
ﬁnishing the 3 protocols are presented in Table 4. TENS applied
at 5Hz on nerve site was the worst tolerated with highest VRS
and VAS, although not signiﬁcantly with respect to the other ES
protocol (P= .056 and P= .11, respectively).
There were no adverse effects at the end of the intervention or
reported afterwards by the subjects.
4. Discussion
This study compared the efﬁcacy of 3 TENS applications.
Increased FV and PV in the ipsilateral popliteal vein were seen
both in nerve and muscle stimulation, and using 1 and 5Hz. This
is concordant with the existing literature, despite ES parameters’
differences andmissing data or discrepancies when reporting it. A
review provided a range of 60% to 615% FV increasing from
baseline and 25% to 650% for PV.[15] The much higher values
were from studies in operated on and healthy people at bed rest
using NMES.[21,22] This can be explained by 2 factors: bed rest
causes a decline in venous blood ﬂow, so a higher increase
compared to resting values can be expected; in addition, in these
researches only the NMES “on time” was compared to baseline,
not considering off time where a subsequent cessation in blood
ﬂow might happen. Few studies have considered percentage of
change, and lower range values have been reported stimulating
common peroneal nerve[9,23] or different muscle locations[17] in
healthy volunteers. In these studies a long-lasting hemodynamic
recording of 15seconds was used, as has been also recorded in the
present study, to deal with cardiac and respiratory variations.
When looking for the differences among the 3 TENS protocols,
TENS at 5Hz (both nerve and muscle) obtained a higher FV than
at 1Hz on nerve site. However, applying TENS on nerve site
(both 1 and 5Hz) achieved higher PV than on muscle location
(with 5Hz). The latter has not been shown in the previous study
comparing nerve and muscle ES, but signiﬁcantly lower VAS was
achieved in nerve site.[16] Likely, the discrepancies may be
attributed to the distinctive current densities, muscle sites, and
frequencies tested.
Current density is estimated as intensity per electrode area.[24]
Whereas in the mentioned study[16] identical current densities
were applied (same intensity and small sized electrodes for both
locations), in the present study the highest tolerated intensity for
Figure 1. Electrodes sites for nerve (left) and muscle (right) electrical
stimulation. Two 3.2cm round self-adhesive electrodes were placed over
the left common peroneal nerve, close to the ﬁbula head. The other pair of 55
cm self-adhesive electrodes was located at the motor points of the soleus
muscle.
Table 1
Subject physical characteristics.
Male (n=12) Female (n=12)
Age, y 22.50±3.23 19.42±0.90
BMI, kg/m2 24.17±2.41 22.17±1.90
Calf perimeter, cm 37.05±1.74 32.93±2.64
Data are presented as means± standard deviation.
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Figure 2. Duplex Doppler ultrasound recordings used for blood ﬂow analysis. Representative capture window measuring popliteal blood ﬂow waveform in basal
condition is displayed at the top left of the image. The response to transcutaneous electrical nerve stimulation at 1Hz applied on nerve site is seen at the top right of
the ﬁgure. The spikes reﬂect the altered ﬂow pattern at the frequency delivered. Effect on waveform of transcutaneous electrical nerve stimulation at 5Hz on nerve
site is located at the bottom left of the picture. More spikes are seen as frequency is increased 5 times. Finally, at the bottom right corner there is the ultrasound
capture window from transcutaneous electrical nerve stimulation at 5Hz with electrodes placed over the soleus muscle. The ﬂow pattern obtained is different from
previous electrical applications as the spikes are less pronounced and there is more regularity in the venous blood ﬂow.
Table 2
Comparison of FV and PV, at baseline and at different protocols of electrical stimulation (n=24).
Baseline Stimulation Difference
Median (Q1–Q3) Median (Q1–Q3) Mean (95% CI) Effect size P
∗
FV, mL/min
1 Hz 80.1 (65.3–100.6) 97.8 (73.9–153.1) 24.49 (9.08, 39.91) 0.320 .003
5 Hz 75.1 (55.5–114.7) 174.0 (120.1–251.2) 115.26 (74.74, 155.79) 0.601 <.001
5 Hz musc 74.0 (60.1–114.8) 182.9 (139.9–266.6) 115.05 (86.10, 144.00) 0.746 <.001
PV, cm/s
1 Hz 13.4 (10.5–18.3) 55.1 (45.4–67.7) 39.93 (34.01, 45.86) 0.894 <.001
5 Hz 13.1 (9.9–17.6) 48.9 (39.4–62.2) 34.61 (28.08, 41.13) 0.839 <.001
5 Hz musc 13.2 (11.2–20.4) 39.2 (29.1–49.4) 23.13 (18.74, 27.53) 0.837 <.001
CI= conﬁdence interval, FV= ﬂow volume, musc=muscle, PV=peak velocity, Q1= ﬁrst quartile, Q3= third quartile.
∗
t test for paired samples.
Table 3
Comparison of the relative increment of FV and PV among the different protocols of electrical stimulation (n=24).
1 Hz 5 Hz 5Hz musc Effect size P
∗
FV (%) 32.6±46.1 146.8±115.9 147.9±99.1 0.482 <.001†
25.2 (3.5, 62.1) 125.8 (70.4, 193.5) 128.6 (77.4, 208.3)
P
∗∗
1Hz-5Hz
‡ <.001 P
∗∗
1Hz-5Hzmusc
‡ < .001 P
∗∗
5Hz-5Hz musc
‡=1.00
PV (%) 291.9±136.2 258.6±126.8 169.7±95.1 0.585 <.001†
299.5 (171.1, 367.6) 257.5 (188.9, 352.7) 166.3 (85.6, 229.6)
P
∗∗
1Hz-5Hz
‡= .22 P
∗∗
1Hz-5Hz musc
‡ <.001 P
∗∗
5Hz-5Hz musc
‡= .002
Data are presented as mean±SD and median (Q1, Q3).
FV= ﬂow volume, musc=muscle, PV=peak velocity, Q1= ﬁrst quartile, Q3= third quartile, SD= standard deviation.
∗
P for differences among ES protocols.
∗∗
P (1Hz vs. 5Hz), (1 Hz vs. 5Hz muscle), and (5Hz vs. 5Hz muscle) using Bonferroni correction.
† ANOVA for repeated measures.
‡ Paired t test.
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each protocol was selected. Indeed, in consonance with ES-
recommended parameters, greater electrode size was chosen for
muscle than for nerve location. Common peroneal nerve was
stimulated at a site where good accessibility is considered[25] and
small electrodes have been found more comfortable and selective
for thin fat layers and superﬁcial nerves.[24]
Tibialis anterior was the chosen muscle site in Izumi et al’s
study,[16] whereas soleus was the stimulated muscle in the present
research. When comparing tibialis anterior and soleus, soleus
expelled higher volume and achieved lower peak velocities, which
were on average 35% lower than tibialis anterior.[19] In another
study testing different muscles (soleus was not included),
gastrocnemius medial was the only muscle where, besides an
increased PV from baseline, a higher FV was detected.[17]
Explanations from the authors in both researches are in
connection with the intimate relationship among the muscles
and plexus of deep veins. The leg pump—located in the veins of
the soleus muscle—and the popliteal pump—located in the
gastrocnemius muscle—are considered together as the calf muscle
pump, which is the most important pump in the lower limb. The
medial gastrocnemius veins play a major role pushing the blood
column upwards and creating an aspiration effect in the popliteal
roots below.[26] These muscles are innervated from the tibial
nerve. Stimulation of the tibial nerve produced nearly identical
hemodynamics responses as voluntary contractions when
controlling force, duty cycle, and active muscle mass.[27]
Regarding the frequency, the previous study used 10Hz on
nerve and 50Hz on muscle site,[16] whereas in this study, 5Hz
was used in both nerve and muscle locations. Other studies have
examined the effect of frequency on venous hemodynamics, with
diverse results. Stimulating the common peroneal nerve (1–40
mA, 1–5Hz), venous FV and PV have been enhanced, with both
intensity and frequency showing moderate to strong positive
correlations.[8] In the present research, increased FV at higher
frequency was also found, but the same relationship between
frequency and PV was not. Different factors can be responsible
for the differences. Likely, the most relevant is using the highest
tolerated intensity, which was lower at 5Hz than at 1Hz,
whereas the same intensities were selected by Izumi et al.[16]
Another study testing 0.13 to 2Hz in amuscle location on the calf
showed that different rates of stimulation had a different effect on
PV and FV, as PV decreased and FV increased.[28] Perhaps the
effect of diminishing PV at increasing frequency is most patent
when comparing to frequencies below 1Hz, as seems to happen
in the graphic data presented in this work.
Basically, 2 factors can be argued to support TENS at 5Hz on
soleus muscle rather than TENS at 5Hz on common peroneal
nerve. First, 5Hz on nerve site originated higher PV increment
and it has been noted than an excessive increase in PV can be
dangerous. TENS has obtained even higher PV than voluntary
exercise when applied at high intensity and pulse duration.[29]
In IPC devices, a decline in blood ﬂow velocity has been found in
the ﬁrst section of deﬂation phase. A negative pressure is
generated in the inner vessel, and it pulls blood into the
decompressed vessels. There is a possibility of a nondesirable
backward ﬂow when a strong negative pressure—related to a
high PV—is generated.[30] This can be ampliﬁed when partial
venous obstruction with stenosis or malfunctioning venous
valves exists, as it creates the conditions for eddy blood ﬂow.[31]
For this reason, other factors related to venous volume have been
proposed to test the different applications.[7,19] Second, when
subjects compared the applications using VRS, 5Hz on muscle
was felt more comfortable than 5Hz on nerve site (close to
statistical signiﬁcance). Discomfort assessment by VRS showed
mild discomfort in 1Hz and 5Hzmuscle. This level of discomfort
is in consonance with the application of 1Hz TENS device (Geko
T-1) at normal clinical use setting.[23]. Despite healthy subjects
have been assessed in the present study, it would be useful for
collecting normative data to help with better treatment choices in
patient population.
5. Limitations
There are 2 main limitations to this study. First, although
increasing venous ﬂow is assumed to correlate with reduction of
thrombosis risk, the data obtained from young healthy people
might not be directly translated to patients with a vascular disease
or at high risk of suffering it. Second, the medium- and long-term
effects of ES can differ from immediate-effects of a brief
intervention investigated in this study.
6. Conclusions
In conclusion, when considering the highest venous FV increase,
the lowest peak venous velocity change, and comparative
tolerance, TENS at 5Hz on soleus muscle is the most beneﬁcial
protocol. Stimulation of the common peroneal nerve reached a
higher increase in peak venous velocity than in muscle location.
Future studies may investigate the ES of tibial nerve and compare
it to common peroneal nerve effects on hemodynamics.
Furthermore, the inﬂuence of frequency and electrode location
parameters on population at high risk from suffering DVT has to
be established.
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